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Periodontal disease is of established etiology in which polymicrobial synergistic ecology
has become dysbiotic under the influence of Porphyromonas gingivalis. Following
breakdown of the host’s protective oral tissue barriers, P. gingivalismigrates to developing
inflammatory pathologies that associate with Alzheimer’s disease (AD). Periodontal
disease is a risk factor for cardiovascular disorders (CVD), type II diabetes mellitus
(T2DM), AD and other chronic diseases, whilst T2DM exacerbates periodontitis. This
study analyzed the relationship between the P. gingivalis/host interactome and the
genes identified in genome-wide association studies (GWAS) for the aforementioned
conditions using data from GWASdb (P < 1E-03) and, in some cases, from the NCBI/EBI
GWAS database (P < 1E-05). Gene expression data from periodontitis or P. gingivalis
microarray was compared to microarray datasets from the AD hippocampus and/or from
carotid artery plaques. The results demonstrated that the host genes of the P. gingivalis
interactome were significantly enriched in genes deposited in GWASdb genes related to
cognitive disorders, AD and dementia, and its co-morbid conditions T2DM, obesity, and
CVD. The P. gingivalis/host interactome was also enriched in GWAS genes from the more
stringent NCBI-EBI database for AD, atherosclerosis and T2DM. The misregulated genes
in periodontitis tissue or P. gingivalis infected macrophages also matched those in the
AD hippocampus or atherosclerotic plaques. Together, these data suggest important
gene/environment interactions between P. gingivalis and susceptibility genes or gene
expression changes in conditions where periodontal disease is a contributory factor.
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INTRODUCTION
Complex chronic diseases such as periodontitis, cardiovascular disease (CVD; including
atherosclerosis, strokes, hypertension, myocardial infarction, congestive heart failure), type 2
diabetesmellitus (T2DM) andAlzheimer’s disease (AD), are increasingly common during advanced
aging and hence place a considerable social and economic burden globally. Porphyromonas
gingivalis is a risk factor for periodontitis and is associated with distal inflammatory pathologies
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including CVD, T2DM, and AD via immune modification
mechanisms. The prevalence of both periodontitis and AD
increases with aging (Silvestre et al., 2017) as do CVD
(Qiu and Fratiglioni, 2015) and T2DM (Yakaryilmaz and
Ozturk, 2017). The aging process itself may contribute to
these conditions, particularly in relation to pathogens, via
immunosenescence. This can decrease resistance to pathogens
due to immunodeficiency but is also accompanied by an increase
in the pro-inflammatory activity of monocytes and macrophages
which can lead to chronic low grade, inflammation, termed
“inflammageing,” which is also associated with AD, CVD, and
T2DM (Fülöp et al., 2016).
Periodontitis is of particular interest because of its known
polymicrobial etiology and a recognized oral microbiome
(Socransky et al., 1998; Aas et al., 2005). The Human Oral
Microbiome Database www.homd.org (Chen et al., 2010). An
uncontrolled oral microbiome may act as a reservoir, from
which opportunistic pathogens can migrate to remote body
organs. P. gingivalis and oral spirochetes for example, associate
with extra-oral niches (Riviere et al., 2002; Poole et al., 2013;
Olsen and Progulske-Fox, 2015). Periodontal pathogens enter the
systemic system through daily bacteraemia following breakdown
of epithelial: endothelial barriers due to the host’s inflammatory
responses and the ability of some pathogens, including P.
gingivalis to attack these barriers (Katz et al., 2000).
Chronic periodontitis is associated with the sporadic form of
AD and other related comorbidities, T2DM, and atherosclerosis
inter alia (Löe, 1981, 1993; Olsen and Singhrao, 2015; Singhrao
et al., 2015; Olsen et al., 2016; Bale et al., 2017; Harding
et al., 2017). Here our focus is on P. gingivalis as the keystone
pathogen, because it is by far the best-researched bacterium
for its contribution to periodontitis (Hajishengallis et al., 2012;
Hajishengallis and Lamont, 2014; Olsen et al., 2016).
Periodontal disease is an inflammatory condition affecting
the tissues supporting teeth in their bony socket and occurs
in aggressive and chronic subtypes. The disease is caused by
polymicrobial dysbiosis with several bacterial species playing
a significant role in tooth loss (Hajishengallis and Lamont,
2014; Olsen et al., 2016). Some of these include Actinomycetem
actinomycetemcomitans, and those belonging to the red complex
(P. gingivalis, Tannerella Forsythia, Treponema denticola).
Others are intermediate colonizers of the sub-gingival biofilm
ecology of the orange complex, (Fusobacterium nucleatum,
Peptostreptococcus micros, Prevotella intermedia, Prevotella
nigrecens, Eubacterium nodatum, and Streptococcus constellates)
(Haffajee et al., 2008) and other species. Together they contribute
to pathological periodontal pocket formation around the tooth.
The importance of P. gingivalis is the bacterium’s ability
to subvert the roles of organ specific inflammatory cells
via a number of virulence factors, the most important
being its lipopolysaccharide (LPS) and gingipains (Singhrao
et al., 2015; How et al., 2016). Once in the new niche, P.
gingivalis induces dysbiosis of local commensals (Harding et al.,
2017) and drives immune reactions in favor of inflammatory
amplification whilst maintaining chronic disease (Olsen et al.,
2017). The inflammatory contribution from periodontitis links
to CVD (atherosclerosis), T2DM and AD and other pathologies.
The American Heart Association (AHA) declared, after an
extensive review of the literature, that periodontal disease was
independently associated with arteriosclerotic vascular disease
(ASVD) (Bale et al., 2017). Similarly, T2DM has been recognized
as a complication of periodontal disease (Löe, 1993) and
periodontitis has been proposed as a risk factor for AD (Kamer
et al., 2015; Harding et al., 2017; Leira et al., 2017) with support
from longitudinal monitoring documented elsewhere (Chen
et al., 2017).
AD is associated with impaired cognition and a number
of pathological lesions, classically amyloid-beta (Aβ) deposits
and hyperphosphorylated neurofibrillary tangles (Goedert et al.,
1991). Many pathogens, (e.g., herpes simplex type 1 (HSV-
1), Chlamydia pneumoniae, Borrelia burgdorferi) (Itzhaki et al.,
2016) as well as P. gingivalis lipopolysaccharide (Wu et al., 2017)
are able to promote Aβ deposition. Aβ has broad-spectrum
antimicrobial effects against bacteria, fungi and viruses (Soscia
et al., 2010; White et al., 2014; Bourgade et al., 2015; Kumar
et al., 2016) and its deposition may result from an innate immune
response to the cerebral invasion of pathogens that have been
associated with AD.
T2DM is a metabolic disorder characterized by hyperglycemia
and insulin resistance. The complications of diabetes result
from long-term elevation of blood glucose levels. Diabetes
has significant impact on gingival and periodontal tissues due
to poor glycaemic control (Löe, 1981). A consequence of
hyperglycaemia is that free sugars circulating in the blood give
rise to advanced glycation end-products (AGEs), which are a
unique inflammatory product. Endothelial cells and monocytes
have receptors that bind AGE products. This in turn has
an impact on gingival tissue vascular permeability through
enhanced breakdown of the periodontium by protease activity
of polymicrobial infections (Embery et al., 2000; Sugiyama et al.,
2012). T2DM is a well-established risk factor for stroke (Chen
et al., 2016) and as a complication of periodontal disease (Löe,
1981). As with AD, numerous (and similar) oral pathogens
have been associated in patients with diabetes (Castrillon
et al., 2015). The pancreatic amyloid (amylin) accumulates
in pancreatic islets in T2DM. Amylin also has antimicrobial
effects and its accumulation may result from an innate immune
response to chronic bacterial infections, ultimately triggering the
inflammatory pathology related specifically to T2DM (Miklossy
and McGeer, 2016).
Periodontitis is associated with age-related diseases such as
atherosclerosis via immune processes leading to dyslipidaemia
in the vessel walls (Libby et al., 2002; Velsko et al., 2014).
These events follow from established periodontitis (Socransky
et al., 1998). One feature of the polymicrobial infection is
that P. gingivalis secretes a peptidyl arginine deiminase enzyme
that can modify proteins prevalent in atherosclerotic lesions
by citrullination (Janssen et al., 2013; Sokolove et al., 2013;
Geraldino-Pardilla et al., 2017). Gearldino-Pardilla et al. reported
that higher levels of autoantibodies against citrullinated proteins
can target citrullinated histone 2B associated with higher
coronary artery calcium scores (amount of calcium in walls of
arteries supplying heart muscle) when compared with lower
antibody levels, suggesting a potential role of seroreactivity to
citrullinated histone in atherosclerosis (Geraldino-Pardilla et al.,
2017).
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All of the aforementioned diseases have both genetic and
environmental components, the latter often related to pathogens,
as is the case for AD (see above), atherosclerosis (Sessa
et al., 2014), and T2DM (Chakraborty et al., 2017). Previous
studies have shown that host genes utilized by oncogenic
viruses relate to cancer susceptibility genes (Rozenblatt-Rosen
et al., 2012) and several genes related to AD are involved
in the life cycles of the many pathogens implicated in this
disorder (HSV-1, C. pneumoniae, Cryptococcus neoformans,
B. burgdorferi, Helicobacter pylori, and P. gingivalis) (Carter,
2011). The HSV-1 and the parasite Toxoplasma Gondii—host
interactomes also overlap with the susceptibility genes of a
variety of neurological and psychiatric diseases (Carter, 2013a,b).
A further study of 110 viruses has shown host/pathogen and
host/host interactome overlaps that are relevant to the genetics
of multiple human diseases (Navratil et al., 2011). These results
support the notion of important relationships between the genes
and proteins used by pathogens and disease susceptibility genes.
These gene/environment interactions are likely to affect disease
manifestation.
In this study, we have compared the P. gingivalis/host
interactome with GWAS susceptibility genes involved in
AD, T2DM and related metabolic (obesity) syndromes, and
atherosclerosis (CVD, strokes). We have also compared the gene
expression profiles derived from periodontitis gingival tissue
or P. gingivalis-treated macrophages with those derived from
AD hippocampal tissue or atherosclerotic plaques from clinical
samples.
METHODOLOGY
The P. gingivalis/host interactome (currently comprised of
3,993 host genes) curated manually, from Pubmed references
is available at http://www.polygenicpathways.co.uk/pgingivalis.
htm, together with a KEGG pathway analysis of the host arm of
this interactome.
Susceptibility genes for a variety of diseases were from two
genome-wide association study (GWAS) databases. The first of
these (GWASdb, http://jjwanglab.org/gwasdb); contains genes
with a P-value cut-off of P < 1E-10−3 (Li et al., 2012). (The
file downloaded was from the August 2015 release (download
GWASdb SNP-Trait file). The second is the more conservative
NHGRI-EBI Catalog (P < 1E × 10−5) posted at (NHGRI-
EBI Catalog, https://www.ebi.ac.uk/gwas/docs) accessed in May
2017 (Macarthur et al., 2017) and this was used for selected
diseases derived from the initial GWASdb analysis. The reported
genes column represents data from the NHGRI-EBI catalog. For
AD only, genes labeled as “Alzheimer’s disease,” or “Alzheimer’s
disease (late onset),” were used. GWASdb contains data from 591
disease entities classified as disease ontology identifier (DOIDs)
according to Disease-Ontology Lite (http://disease-ontology.
org/) (Kibbe et al., 2015). However, many of the keywords
used for the searches were general (for example, brain disease,
cardiovascular system disease) and these were ignored in favor
of more specific identities of interest (e.g., Alzheimer’s disease,
atherosclerosis, myocardial infarction), (N = 285). In addition,
we compared the P. gingivalis interactome with the proteome of
mouse cerebral arteries from the circle of Willis (6,630 proteins)
(Badhwar et al., 2014). The proteins from this area of the anatomy
is relevant because arteries supplying blood to the brain branch
out at the circle of Willis and are subject to atherosclerosis in AD
(Roher et al., 2003).
Next, we compared the microarray gene expression studies for
periodontitis or P. gingivalis with the microarray datasets from
AD and/or with atherosclerosis. The periodontitis microarray
data are from an integrated analysis of three microarray datasets
from human gingival tissue obtained from periodontitis patients
(Guo et al., 2015). The effects of P. gingivalis relate to a
microarray study of human macrophages exposed to live P.
gingivalis, its LPS, or its fimbrial component (fimbrillin =
FimA), 2h post infection or treatment; (Affymetrix Human
Genome U133 Plus 2.0 array) (Zhou and Amar, 2007). These
effects (periodontitis or P.gingivalismicroarrays), were compared
with microarray datasets obtained from post-mortem studies
of the AD hippocampus for incipient and/or established AD
(nine control and 22 AD subjects of varying severity on
31 separate microarrays, Affymetrix Human Genome U133A)
(Blalock et al., 2004); and from a study comparing stable vs.
unstable atherosclerotic plaques derived from human carotid
endarterectomy specimens (Total RNA from 11 segments from
3 atherosclerotic plaques classified as stable and unstable:
Affymetrix Human Genome U133). The expression data
refer to stable/unstable atherosclerotic plaques comparisons
(Papaspyridonos et al., 2006). Gene symbols for all data conform
to the Human gene Nomenclature (HUGO) system (Povey
et al., 2001). Overlapping gene symbols from the comparisons
were with the Venny tool, online at the following URL (http://
bioinfogp.cnb.csic.es/tools/venny/) (Oliveros, 2007).
Statistical Analysis
Assuming a human genome of 26,846 coding genes and a P.
gingivalis interactome of 3,993 host genes, 3,993/26,846 gene sets
would be expected in any comparator GWAS or other dataset
(14.87%). This calculation allowed the determination of the
expected values and the enrichment values (observed/expected)
in relation to the GWASdb or NHGRI-EBI datasets. The same
approach was used to compare microarray data, using the
number of misregulated disease genes (=N) to define expected
percentage overlap values (=N/26846%). Statistical significance
of the enrichment was calculated using the hypergeometric
probability test where a Bonferroni cut-off (0.05 × 591 = <
0.0000846) was applied. The resultant p-values from each of the
analyzed series, was corrected for, by accounting for the false
discovery rate (FDR p=q) (Benjamini and Hochberg, 1995).
Significant FDR corrected values are considered at q < 0.05. The
KEGG Pathway enrichment analysis was determined using the
Consensus Path database (CPDB) at http://cpdb.molgen.mpg.de/
(Herwig et al., 2016).
RESULTS
The P. gingivalis interactome was highly enriched in GWASdb
genes related to neurological disorders (cognitive disorder,
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dementia and AD), and with metabolic disorders (T2DM and
obesity). Each of these conditions has been associated with
periodontal disease, as referenced in Table 1. The analysis
showed P. gingivalis bacterial interactome enrichment in
GWASdb genes for CVD including those for hypertension,
diverse atherosclerotic conditions, myocardial infarction and
congestive heart failure. Similarly, the interactome also related to
GWASdb genes from several psychiatric conditions or substance
abuse-related disorders that link to periodontal disease (as
referenced in Table 1); and are related to mood, depression,
anxiety and sleep disorders as well as to substance dependence,
including nicotine and alcohol dependency (Table 1). Such a
finding was further strengthened by interactome enrichment
confirmation in relation to the more stringent NHGRI-EBI
GWAS database (P < 1E-05) for genes related to AD,
T2DM, and atherosclerosis (= carotid plaque burden in
the NHGRI-EBI GWAS database). Other diseases were not
analyzed.
The overlap between the P. gingivalis interactome and
periodontitis/periodontal disease (GWASdb) was not significant
for 51 GWASdb genes, but was nominally significant (p
= 0.029) for 108 periodontitis genes from the NHGRI-
EBI Catalog. This lack of, or low significance may relate
to the fact that numerous other pathogens are involved in
causing chronic periodontitis (Table 1). It could also be
related to statistical power problems inherent to this type of
analysis (a fixed number of the P. gingivalis interactome (N
= 3993) and variable numbers of GWASdb susceptibility
genes (from 51 in periodontitis to 4,763 in cognitive
disorder).
A Focus on AD, T2DM, Atherosclerosis and
Hypertension
The P. gingivalis interactome overlaps with GWASdb genes
associated with each of these (AD, T2DM, atherosclerosis
and hypertension) diseases or risk factors. Some of these
interactome overlaps are with genes specific to either single
diseases or risk factors (diabetes = N = 417; hypertension
N = 193; AD = N = 131; atherosclerosis N = 39).
In other cases, overlapping interactome genes are common
to two or more diseases such as, AD/diabetes N = 105;
AD/atherosclerosisN = 22; AD/atherosclerosis/diabetesN = 11;
(AD/atherosclerosis/hypertension N = 5) (Figure 1). Twenty-
three of seventy-eight AD genes from the more stringent
NHGRI–EBI GWAS database (p < 1E-05) also appeared in these
four datasets (Figure 1).
Over-Representation of Arterial Genes in
the P. gingivalis Interactome
Of the full P. gingivalis interactome (3,993 genes), 1,423 belonged
to the cerebral artery proteome dataset of 6,630 proteins (21.4%:
Observed/expected= 1.44: enrichment: P= 7.2E-63). Of the 385
genes common to the P. gingivalis interactome and ADGWASdb
genes, 175 belonged to the cerebral artery proteome: (45.3%;
observed/expected= 1.85: enrichment P = 0).
KEGG Pathway Analysis of the AD Genes
Common to the P. gingivalis Interactome
The analysis of pathways outlined by the GWASdb genes
common to AD and the P. gingivalis interactome generated
by the CPDB website, are in Table 2. (KEGG pathways for
the entire host/pathogen interactome are posted at http://
www.polygenicpathways.co.uk/pgingkegg.html. These genes
include pathways related to cancers, AD, infection and
immune responses, cytokine and chemokines and multiple
metabolic signaling processes). KEGG pathway analysis of the
common AD/interactome genes revealed pathways relevant to
blood-brain barrier (BBB) function, including focal adhesion,
junction and actin pathways, protein digestion and absorption
(mainly represented by collagen genes that are related to
vascular smooth muscle, and leukocyte trans endothelial
migration).
Microarray Studies of Periodontitis or
P. gingivalis: Comparison with Alzheimer’s
Disease and Atherosclerosis
Periodontitis Comparison
The genes upregulated in periodontitis significantly overlapped
with those upregulated in the AD hippocampus [mature AD (P
= 3.9E-30), incipient AD (P = 4.6E-14)] and in atherosclerotic
plaques (P = 1.7E-13) (Figure 2A). There was also significant
match between the genes downregulated in periodontitis and
those downregulated in mature AD (P = 5.6E-31), incipient
AD (P = 3.5E-51) and atherosclerotic plaques (P = 9.8E-97)
(Figure 2B).
P. gingivalis Comparison
In general, the overlaps between the P. gingivalis microarrays
(live, LPS, or FimA effects in macrophages) and the misregulated
genes in AD or atherosclerosis were fewer and less significant,
than when compared with periodontitis, where a more
diverse microbial population is encountered (Figures 2A,B).
The genes upregulated in AD significantly matched those
upregulated by live P. gingivalis (mature AD: P = 1.1E-
08: incipient AD: P = 0.0003), its LPS (mature AD: P =
0.0002: incipient AD: P = 0.005) or FimA (mature AD:
P = 3.2E-07: incipient AD P = 0.0006) (Figure 2A). The
genes downregulated in incipient AD matched those affected
by live P. gingivalis infection (P = 1.1E-08) or its FimA (P
= 3.4E-06) but the comparisons between mature AD and
live P. gingivalis or its FimA component were not significant
(Figure 2B).
The genes upregulated in atherosclerotic plaques also
matched those affecting macrophages by live P. gingivalis
(P = 0.0005) infection, or its FimA component (P =
0.013). The LPS comparison was not significant (P = 0.06).
The effects of live P. gingivalis, were significant for the
genes downregulated in the atherosclerosis comparison (P
= 9.2E-10). The FimA comparison was not significant (P
= 0.06) and no downregulated data were available for the
bacterial LPS.
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TABLE 1 | The overlaps between the host genes of the P. gingivalis interactome with genes associated with diverse diseases from the GWASdb (top unshaded region) or
the NCBI-EBI (bottom shaded region) databases.
Condition Association references N GWAS Overlap Expected O/E Hypergeometric
P-value
FDRp
Periodontal
Periodontitis: DOID:824 or
periodontal disease DOID:3388
(same genes)
Periodontal pathogens include
A. actinomycetemcomitans, (P. gingivalis,
T. forsythia, T. denticola) others (F. nucleatum,
P micros, P. intermedia, P. nigrecens,
E. nodatum, and S. constellates) (Socransky
et al., 1998)
51 11 7 1.47 0.059 NA
Neurological
Cognitive disorder: DOID:1561 Periodontitis has been associated with
cognitive decline in middle-aged and older
adults (Noble et al., 2009; Naorungroj et al.,
2013; Shin et al., 2016) and in Alzheimer’s
disease (AD) (Ide et al., 2016)
4,763 1,065 698 1.53 1.98E-53 8.36E-52
Dementia: DOID:1307 See AD: Among those aged 75years or older,
patients with AD or other types of dementias
are at increased risk of poor oral health and
poor oral hygiene (Syrjälä et al., 2012). Vascular
dementia patients have higher number of
decayed teeth and deeper periodontal pockets
(Bramanti et al., 2015)
1,645 400 241 1.66 7.96E-26 1.34E-24
Alzheimer’s disease:
DOID:10652
Periodontitis has been associated with AD
(Noble et al., 2009; Sparks Stein et al., 2012;
Singhrao et al., 2015) and P. gingivalis
lipopolysaccharide detected in AD brains
(Poole et al., 2013)
1,591 385 233 1.65 1.84E-24 2.86E-23
Metabolic
Type 2 diabetes mellitus:
DOID:9352
Periodontitis is associated with type 2 diabetes
and higher colonization levels of several
periodontal pathogens, including P. gingivalis
are associated with higher prediabetes
prevalence among diabetes-free adults
(Demmer et al., 2015). In mice, diabetes
increases the risk for periodontal disease
induced by P. gingivalis but infection did not
affect the onset or severity of diabetes in either
type 1 or 2 diabetes mice (Li et al., 2013)
3,381 817 495 1.65 2.25E-53 8.86E-52
Obesity: DOID:9970 Periodontal pathogens, including P. gingivalis
are prevalent in the mouth and stomach of
obese individuals undergoing bariatric surgery
(Pataro et al., 2016). Bacteria, including
P. gingivalis associated with body mass index
and waist circumference in Japanese subjects
(Matsushita et al., 2015)
2,076 501 304 1.65 1.6E-31 3.49E-30
Cardiovascular
Hypertension: DOID:10763 Hypertension and atherosclerosis have been
associated with antibodies to P. gingivalis
(Hanaoka et al., 2013)
1,883 496 276 1.80 1.36E-41 3.48E-40
Arteriosclerosis: DOID:2349 Periodontal bacteria including
A. actinomycetemcomitans, P. gingivalis,
T. forsythia, T. denticola or F. nucleatum are
believed to contribute to atherosclerosis via
effects on lipoprotein serum concentration,
endothelial permeability and binding of
lipoproteins in the arterial intima (Bale et al.,
2017). P. gingivalis is the most abundant of
over 200 bacterial species detected in
non-atherosclerotic coronary and femoral
arteries (Mougeot et al., 2017)
823 207 121 1.72 1.73E-15 1.96E-14
Arteriosclerotic cardiovascular
disease: DOID:2348
514 130 75 1.73 1.68E-10 1.34E-09
Atherosclerosis: DOID:1936 500 126 73 1.72 3.97E-10 3.08E-09
(Continued)
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TABLE 1 | Continued
Condition Association references N GWAS Overlap Expected O/E Hypergeometric
P-value
FDRp
Myocardial infarction: DOID:5844 A Danish register study (17,691 periodontitis
patients) has shown association with
myocardial infarction, ischemic stroke,
cardiovascular death, and major adverse
cardiovascular events (Hansen et al., 2016)
705 180 103 1.74 2.71E-14 2.71E-13
Congestive heart failure:
DOID:6000
Periodontitis has been associated with heart
failure (Wood and Johnson, 2004; Fröhlich
et al., 2016; Holmlund et al., 2017). No specific
reports for P. gingivalis
233 71 34 2.08 6.27E-10 4.80E-09
Psychiatric
Mood disorder: DOID:3324 See depression 2,536 582 372 1.57 1.84E-30 3.87E-29
Substance dependence:
DOID:9973
See alcohol and nicotine 1,518 380 223 1.71 4.57E-27 7.92E-26
Alcohol dependence:
DOID:0050741
High levels of periodontal pathogens, including
P. gingivalis observed in alcoholic patients
(Amaral et al., 2011; Sender-Janeczek and
Zietek, 2016). Alcohol consumption is a risk
factor for periodontitis (Shepherd, 2011)
1,139 283 167 1.69 6.93E-20 9.08E-19
Nicotine dependence:
DOID:0050742
Low concentrations of cigarette smoke
condensate increase invasion of human
gingival epithelial cells by P. gingivalis (Imamura
et al., 2015)
542 149 79 1.87 8.26E-15 8.71E-14
Anxiety disorder: DOID:2030 Social stress enhances the inflammatory
response to P. gingivalis in mice (Bailey et al.,
2009)
360 91 53 1.7 7.38E-08 4.35E-07
Sleep disorder: DOID:535 Periodontal disease has been associated with
obstructive sleep apnoea (meta-analysis) (Al
Jewair et al., 2015). Sleep deprivation
increases periodontitis in a rat model (Nakada
et al., 2015). No reports for P. gingivalis.
247 67 36 1.85 2.31E-07 1.22E-06
Endogenous depression:
DOID:1595/major depressive
disorder: DOID:1470 (same
genes)
The incidence of depression is higher in
patients with periodontitis (Hsu et al., 2015;
Kumar et al., 2015). No specific links found for
P. gingivalis
510 109 75 1.46 1.73E-05 6.99E-05
Blood disorders
Leukopenia: DOID:615 See agranulocytosis 995 225 146 1.54 1.08E-11 9.27E-11
Agranulocytosis: DOID:12987 = Neutropenia: Neutropenia has been
associated with prepubertal periodontitis and
with the subgingival microflora, including
P. gingivalis (Kamma et al., 1998)
376 99 55 1.80 2.44E-09 1.73E-08
NCBI-EBI GWAS
Alzheimer’s disease 78 32 11.4 2.8 1.47E-08 5.90e-08
Type 2 diabetes 217 58 31.8 1.82 2.18E-06 4.35E-06
Atherosclerosis carotid plaque
burden)
46 14 6.7 2.08 0.0035 0.0047
Periodontitis 108 22 15.8 1.39 0.029 0.029
The total number of associated GWAS genes (N GWAS) is shown for each disease, together with the number of these genes common to the P. gingivalis interactome (overlap). The
expected number of common genes and the observed/expected ratios (O/E) are also shown together with the p-value for enrichment and the P-value corrected for false discovery
(FDRp). NS, non-significant (see section Methodology).
DOID, Disease Ontology identifier; O/E, ratio of overlapping genes to expected genes; O, genes found to overlap with P. gingivalis interactome; E, number of genes expected to overlap
by random chance; FDRq, p (q)-value corrected for False discovery.
DISCUSSION
P. gingivalis is but one of several pathogens contributing
to periodontal disease and this may contribute to the lack
of (GWASdb) or low significance (NHGRI–EBI) of the
overlap between the host/pathogen interactome and the genes
associated with periodontitis itself. Many individuals do not
develop periodontitis during their lifetime (Trombelli et al.,
2004). Progression to the aggressive form of periodontitis
is also rare and is associated with neutrophil defects with
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FIGURE 1 | Venn diagram shows the number of susceptibility genes (GWASdb) and their percentage occurrence within the P. gingivalis/host interactome that are
common or specific to various combinations of atherosclerosis (Athero), type 2 diabetes (Diab), hypertension (hyper) and Alzheimer’s (Alz), The Venn diagram is for
data from GWASdb. The genes in boxes refer to GWAS genes from the more stringent NCBI-EBI data that are also part of the P. gingivalis/host interactome. The
percentages are those of the sum of the interactome/susceptibility gene overlaps for all diseases represented in the figure (atherosclerosis+ type 2 diabetes +
hypertension+ Alzheimer’s gene/interactome overlaps).
A. actinomycetemcomitans as the dominant etiological agent
(Zambon, 1985), whereas chronic periodontitis is associated with
complexes containing mixtures of species such as P. gingivalis,
T. forsythia and a range of spirochetes (Socransky et al., 1998;
Haffajee et al., 2008). Given the relationship between pathogens
and host genes, as exemplified in this paper, such clinical variables
may also depend upon the host’s genetic profile. However, the
enrichment of the interactome in genes associated with many
other diseases linked to periodontitis (e.g., AD, CVD, and T2DM)
was highly significant. This suggests that, within the sub-gingival
microbiome, P gingivalis is a key pathogen contributing to the
pathologies of these diseases. The focus of this paper relates
principally to AD through these comorbid states.
The oral pathogen P. gingivalis interacts with or alters the
expression of thousands of host genes forming an extensive
host/pathogen interactome. The genes of the host arm of this
interactome overlap with GWASdb genes associated with AD,
atherosclerosis and T2DM and other CVD complications
including hypertension and myocardial infarction. They
also overlap with GWASdb genes associated with several
psychiatric conditions and/or psychological factors determining
life-styles including mood disorders, depression, anxiety
and sleep disorders and substance abuse. Periodontitis can
affect mood, depression, anxiety and sleep disorders as
discussed previously (Harding et al., 2017) and the outcome
of this interactome analysis supports this related conclusion.
In addition, dependency on drugs including nicotine and
excessive alcohol intake can negatively affect oral hygiene
and periodontitis (Bonfim et al., 2013; Singh et al., 2013) and
subsequently mental health as a bi-directional association (oral
health <> mental health) (Kisely, 2016). The overlap between
the genes associated with nicotine and alcohol abuse and the
P. gingivalis interactome (Table 1) may relate to the effects of
nicotine or alcohol on host genes affecting pathogen levels and
virulence. For example, nicotine reduces the induction of the
anti-microbial beta-defensin-2 induced by P. gingivalis LPS in
human gingival epithelial cells (Mahanonda et al., 2009), and
even low concentrations of cigarette smoke condensate increase
invasion of human gingival epithelial cells by P. gingivalis
(Imamura et al., 2015). In general, both alcoholism and smoking
can modify cytokine responses to bacterial LPS or lipoteichoic
acid in systemic immune cells (Gaydos et al., 2016).
Polymorphisms in human genes affect host physiology,
but they are also likely to affect the interactions between
pathogen and host. Pathogens also use these host genes/proteins
during their life cycles, and the host employs many immune,
inflammatory and defensive genes against the pathogens.
Modifications in the host genes must also impinge on these
effects. As previously discussed (Carter, 2013a,b), disease
susceptibility genes relevant to pathogens may thus divert the
effects of the pathogen toward or away from particular pathways,
thus orientating its adverse effect to directions that enable it
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TABLE 2 | KEGG pathway enrichment analysis of the genes common to GWASdb AD genes and the P. gingivalis interactome.
KEGG pathway p-value q-value Overlapping genes
BARRIER RELATED
Focal adhesion 0.0001 0.006 ACTN1; PTK2; PDGFD; PRKCA; ITGA1; ITGA4; MYLK; AKT3; MAPK10; COL4A2;
COL4A1; ACTB; BCAR1; EGF
Protein digestion and absorption 0.0002 0.006 COL18A1; COL14A1; COL5A2; SLC8A1; COL27A1; COL4A2; COL4A1; MME; DPP4
Vascular smooth muscle contraction 0.001 0.019 GNAS; PRKCA; PRKCE; RAMP1; MYLK; KCNMA1; PRKG1; ITPR3; CALD1
Leukocyte transendothelial migration 0.004 0.03 ACTN1; PTK2; PRKCA; ITGA4; RASSF5; PTK2B; ACTB; BCAR1
Adherens junction 0.005 0.03 TGFBR2; ACTN1; SMAD3; PTPRB; PTPN1; ACTB
Gap junction 0.013 0.07 PDGFD; GNAS; PRKCA; PRKG1; ITPR3; EGF
Regulation of actin cytoskeleton 0.02 0.08 ACTN1; PTK2; PDGFD; CYFIP2; ITGA1; ITGA4; MYLK; ACTB; BCAR1; EGF
DISEASES
Arrhythmogenic right ventricular cardiomyopathy 0.0001 0.006 ACTN1; ITGA1; CACNB1; SGCD; ITGA4; SLC8A1; LMNA; ACTB
Pathways in cancer 0.0002 0.006 TGFBR2; NOS2; PTK2; AXIN1; GNAS; MECOM; RASSF5; SMAD3; CSF1R; CYCS;
PRKCA; GLI2; PPARG; AKT3; GNG2; COL4A2; COL4A1; GNB4; MAPK10; EPAS1;
EGF
Dilated cardiomyopathy 0.0008 0.013 GNAS; ITGA1; CACNB1; SGCD; ITGA4; SLC8A1; ACTB; LMNA
Hypertrophic cardiomyopathy 0.002 0.023 ITGA1; CACNB1; SGCD; ITGA4; SLC8A1; LMNA; ACTB
Colorectal cancer 0.002 0.023 TGFBR2; AXIN1; CYCS; SMAD3; AKT3; MAPK10
Non-small cell lung cancer 0.008 0.04 PRKCA; FOXO3; AKT3; RASSF5; EGF
Small cell lung cancer 0.011 0.06 NOS2; PTK2; CYCS; AKT3; COL4A2; COL4A1
Pancreatic cancer 0.015 0.07 TGFBR2; AKT3; MAPK10; EGF; SMAD3
Endometrial cancer 0.03 0.09 FOXO3; AKT3; EGF; AXIN1
Insulin resistance 0.03 0.1 PPP1R3B; PRKCE; AKT3; MAPK10; PTPN1; CREB3L1
Alzheimer’s disease 0.04 0.11 APOE; ATP2A3; CYCS; GRIN2A; MAPT; SNCA; MME; ITPR3
Transcriptional misregulation in cancer 0.045 0.12 TGFBR2; PTK2; CSF1R; HMGA2; AFF1; CD86; PPARG; MEIS1
IMMUNE
AGE-RAGE signaling pathway in diabetic complications 0.0003 0.008 TGFBR2; PRKCA; PRKCE; SMAD3; AKT3; JAK2; COL4A2; COL4A1; MAPK10
Hematopoietic cell lineage 0.005 0.033 CR1; CSF1R; ITGA1; CD33; ITGA4; IL6R; MME
Inflammatory mediator regulation of TRP channels 0.02 0.09 GNAS; CAMK2D; PRKCE; PRKCA; MAPK10; ITPR3
Th17 cell differentiation 0.03 0.1 STAT6; TGFBR2; SMAD3; JAK2; MAPK10; IL6R
SIGNALING
Calcium signaling pathway 0.0002 0.006 NOS2; GNAS; CAMK2D; ATP2A3; MYLK; CACNA1G; PRKCA; ADRB2; PTK2B;
SLC8A1; ITPR3; ATP2B2; GRIN2A
PI3K-Akt signaling pathway 0.0002 0.006 PTK2; PDGFD; OSMR; GHR; CSF1R; PRKCA; ITGA1; EFNA5; ITGA4; IL6R; FOXO3;
AKT3; JAK2; COL4A2; COL4A1; GNB4; GNG2; EGF; CREB3L1
Circadian entrainment 0.0003 0.007 GNAS; CAMK2D; GNB4; PRKG1; CACNA1G; PRKCA; GRIN2A; GNG2; ITPR3
cGMP-PKG signaling pathway 0.001 0.019 ATP2A3; PRKCE; MYLK; KCNMA1; ADRB2; AKT3; PRKG1; SLC8A1; ITPR3;
ATP2B2; CREB3L1
Rap1 signaling pathway 0.003 0.024 PDGFD; GNAS; PRKCA; RASSF5; EFNA5; CSF1R; AKT3; ACTB; SIPA1L2; BCAR1;
EGF; GRIN2A
ErbB signaling pathway 0.003 0.025 PTK2; NCK2; CAMK2D; PRKCA; AKT3; MAPK10; EGF
Ras signaling pathway 0.005 0.032 PDGFD; PRKCA; CSF1R; EFNA5; RASSF5; PLA1A; AKT3; MAPK10; GNB4; GNG2;
EGF; GRIN2A
Adrenergic signaling in cardiomyocytes 0.006 0.033 GNAS; CAMK2D; CACNB1; PRKCA; ADRB2; AKT3; SLC8A1; ATP2B2; CREB3L1
Phospholipase D signaling pathway 0.014 0.07 PDGFD; GNAS; PRKCA; EGF; PTK2B; AKT3; GRM8; DGKI
GnRH signaling pathway 0.016 0.07 GNAS; CAMK2D; PRKCA; PTK2B; MAPK10; ITPR3
Hippo signaling pathway 0.02 0.08 TGFBR2; AXIN1; WWC1; SMAD3; GLI2; ACTB; FRMD6; TEAD4
MAPK signaling pathway 0.03 0.09 TGFBR2; MECOM; CACNB1; CACNA1G; PRKCA; AKT3; MAPK10; MAPT; RELB;
DUSP16; EGF
HIF-1 signaling pathway 0.03 0.09 NOS2; CAMK2D; IL6R; PRKCA; AKT3; EGF
cAMP signaling pathway 0.03 0.1 GNAS; CAMK2D; CREB3L1; ADRB2; AKT3; MAPK10; ABCC4; ATP2B2; GRIN2A
NEURAL
Dopaminergic synapse 0.0006 0.012 GNAS; CAMK2D; CREB3L1; PRKCA; AKT3; GNG2; MAPK10; GNB4; ITPR3;
GRIN2A
Axon guidance 0.002 0.023 SEMA3A; PTK2; NGEF; SEMA5A; NCK2; CAMK2D; EFNA5; PRKCA; ABLIM1;
EPHA5; SEMA5B
(Continued)
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TABLE 2 | Continued
KEGG pathway p-value q-value Overlapping genes
Cholinergic synapse 0.003 0.025 CAMK2D; GNB4; PRKCA; GNG2; AKT3; JAK2; ITPR3; CREB3L1
Glutamatergic synapse 0.004 0.027 GRM8; GNAS; PRKCA; GNB4; GRIK2; GRIN2A; GNG2; ITPR3
Amphetamine addiction 0.02 0.07 CAMK2D; PRKCA; GRIN2A; CREB3L1; GNAS
Long-term depression 0.04 0.12 PRKCA; ITPR3; PRKG1; GNAS
HORMONES/SECRETION
Gastric acid secretion 0.001 0.019 GNAS; CAMK2D; MYLK; KCNK2; PRKCA; ITPR3; ACTB
Aldosterone synthesis and secretion 0.002 0.024 GNAS; CAMK2D; PRKCE; CACNA1G; PRKCA; CREB3L1; ITPR3
Vasopressin-regulated water reabsorption 0.003 0.024 DYNC1I1; CREB3L1; GNAS; DYNC2H1; DYNC1H1
Salivary secretion 0.004 0.027 GNAS; PRKCA; KCNMA1; ADRB2; PRKG1; ITPR3; ATP2B2
Insulin secretion 0.01 0.06 GNAS; CAMK2D; KCNMA1; PRKCA; CREB3L1; ITPR3
Pancreatic secretion 0.02 0.08 ATP2A3; PRKCA; GNAS; KCNMA1; ITPR3; ATP2B2
INFECTION
Amoebiasis 0.006 0.033 ACTN1; PTK2; GNAS; PRKCA; NOS2; COL4A2; COL4A1
Salmonella infection 0.01 0.06 NOS2; DYNC1I1; MAPK10; DYNC1H1; ACTB; DYNC2H1
Hepatitis B 0.016 0.07 STAT6; PRKCA; CYCS; SMAD3; PTK2B; AKT3; MAPK10; CREB3L1
Tuberculosis 0.018 0.07 NOS2; CR1; CAMK2D; LSP1; CYCS; AKT3; JAK2; MAPK10; PIK3C3
Chagas disease (American trypanosomiasis) 0.028 0.09 TGFBR2; NOS2; GNAS; SMAD3; AKT3; MAPK10
Viral myocarditis 0.039 0.11 ACTB; SGCD; CYCS; CD86
OTHER
Choline metabolism in cancer 0.02 0.09 PDGFD; PRKCA; DGKI; AKT3; MAPK10; EGF
beta-Alanine metabolism 0.03 0.1 ALDH6A1; ALDH1A3; DPYD
Regulation of lipolysis in adipocytes 0.035 0.1 ADRB2; AKT3; PRKG1; GNAS
Osteoclast differentiation 0.0025 0.02 TGFBR2; SQSTM1; CSF1R; PPARG; AKT3; MAPK10; TNFRSF11B; TREM2; RELB
Apoptosis 0.036 0.106164 CASP6; CYCS; AKT3; MAPK10; ITPR3; ACTB; LMNA
The statistical significance (p-values) and false discovery corrected P-values (q-values) as determined by the CPDB website.
to influence diverse diseases in a manner that depends on the
genetics of the host. The effects of P. gingivalis on colonization,
biofilm formation, immune responses and endothelial cell
activation are also strain-dependent (Walter et al., 2004; Belanger
et al., 2008; Wilensky et al., 2009; Barbosa et al., 2015) and
it is likely that distinct host gene relationships and disease
relationships exist for strains with differing virulence.
In this study, the host genes of the bacterial interactome
coincided with a high degree of significance with susceptibility
genes related to cognitive disorders, AD and dementia, as well
as with genes related to obesity and T2DM, and to those
related to atherosclerosis and related disorders. This study adds
significance to periodontal disease or P. gingivalis infection
having associations with all of these conditions. The P. gingivalis
interactome related to genes specifically or commonly associated
with AD, atherosclerosis, diabetes and hypertension as depicted
in the Venn diagram. These conditions are inter-related. For
example diabetes (Shinohara and Sato, 2017), atherosclerosis
(Hofman et al., 1997), and hypertension (de la Torre, 2006)
are all associated with AD, as is obesity (Milionis et al.,
2014). P. gingivalis may contribute to each condition in diverse
ways via these host/pathogen interactions. The pathogen may
thus influence AD risk both directly and via its influence on
these other AD risk factors. There have been fewer studies
relating periodontal disease to psychiatric disorders such as
schizophrenia (McCreadie et al., 2004) but this study suggests
that any such relationship may also have genetic components.
The relationship between periodontitis or P. gingivalis and
AD or atherosclerosis is supported by the transcriptome analyses
studies. The gene expression signatures in periodontal disease
tissue or in macrophage responses to P. gingivalis components
significantly matched those from the AD hippocampus or from
atherosclerotic plaques in most cases, particularly in relation
to the upregulated genes. In the case of the AD hippocampal
transcriptome the upregulated genes contain the pathways
relevant to pathogens and immune activation (inflammation,
complement activation, and the defense response) (Blalock
et al., 2004). The degree of significance was higher for the
periodontal disease transcriptome and this may reflect the
contribution of many other pathogens involved in periodontitis.
AD (Itzhaki et al., 2016) and atherosclerosis (Sessa et al.,
2014; Budzynski et al., 2016) have also been associated with
multiple pathogens and recent microbiome studies have reported
numerous bacterial and fungal species, some of oral origin,
in the AD brain (Emery et al., 2017; Pisa et al., 2017). In
relation to AD, the KEGG pathway analysis of the overlap
between the interactome/AD genes provides some clues as to
how P. gingivalis may contribute to AD. Many significantly
affected pathways relate to breakdown of functional barriers
and to the immune system and inflammatory pathways. The
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FIGURE 2 | (A,B) The number of overlapping genes and the significance of enrichment in comparisons of the effects of periodontitis in human oral tissue or P.
gingivalis in human macrophages with microarrays from the AD hippocampus or from unstable atherosclerotic plaques (Athero). (A) Upregulated genes; (B)
Down-regulated genes. Pdont, periodontitis; Pg live, live P. gingivalis; Pg LPS, P. gingivalis-lipopolysaccharide; Pg Fima, P. gingivalis fimbrial component. The labels on
the X-axis (e.g., Pdont | 1.96 | 2371) correspond to these conditions, followed by observed/expected values, and the number of misregulated genes in the
periodontitis or P. gingivalis microarrays. The maximum of the Y-axis (FDR q-value) is set at p = 0.05 and invisible points above this line are non-significant. No
down-regulated data were available for down-regulated genes in the case of P. gingivalis LPS. The number of up or down-regulated genes in the Alzheimer’s (Alz) or
atherosclerosis datasets are also shown.
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host genes of the bacterial interactome were also highly
enriched in those found in the cerebral artery of the circle of
Willis.
Periodontitis and atherosclerosis can be induced in
apolipoprotein E knockout (ApoE−/−) mice (Velsko et al.,
2014). We have reported such investigations (Poole et al., 2015;
Singhrao et al., 2017). A recent study using the same ApoE−/−
P. gingivalis-infected mice brains (24 weeks) provided evidence
of BBB deterioration, and cerebral tissue damage (Singhrao et al.,
2017). The BBB breach may have resulted from acute phase
inflammation in the form of oxidative stress and P. gingivalis
protease (gingipains) activity in these mice (Rokad et al., 2017;
Singhrao et al., 2017). Gingipains have been shown to degrade
collagens (Bedi and Williams, 1994; Zhou and Windsor, 2006),
and cell-cell adhesion molecules (cadherins and integrins)
contributing to endothelial and epithelial barrier disruption
(Katz et al., 2000; Hintermann et al., 2002; Sheets et al., 2005).
Disruption of the BBB is an early feature of AD (van de Haar
et al., 2016), and P. gingivalis may be one of the many factors
contributing to this adverse outcome. The weakened BBB may
enable the cerebral entry of other pathogens (viral, fungal, and
bacterial origin), that are detected in AD brains. The leaky BBB
might also favor the entry of other environmental toxins (e.g.,
pesticides, pollution, aluminum, or heavy metals) that have been
associated with Aβ fibrils in AD (Carter, 2017). In addition, the
P. gingivalis interactome was highly enriched in cerebral arterial
genes, which further supports the correlation with BBB damage.
Although P. gingivalis LPS is able to provoke Aβ deposition
(Wu et al., 2017), the bacterial interactome genes overlapping
with the AD GWASdb genes were not significantly enriched in
the KEGG AD pathway, suggesting that the BBB-related effects
of P. gingivalis may be of greater relevance to its developing
pathology. In the periphery, vessel damage likely by gingipains
may also allow bacteria to enter the circulatory system and
cause transient bacteraemia that contribute to atherosclerosis
(Bahrani-Mougeot et al., 2008; Lockhart et al., 2008; Singhrao
et al., 2017) and possibly insulin resistance. The endothelial
vessel barrier is disrupted in diabetes and in atherosclerosis
(Chistiakov et al., 2015; Dong et al., 2016) showing common
defects with AD.
There are several general caveats to this type of analysis.
For example, the susceptibility gene/interactome overlaps deal
with gene symbols rather than with specific polymorphisms, and
there have been no studies linking host genetic polymorphisms
to specific components of the P. gingivalis life cycle. The
effects of the pathogen may also be strain-specific and some
strains may be more virulent. Within any large interactome,
effects in relation to the host may be null, deleterious or
even beneficial. The statistical analyses similarly rely on the
degree of overlap between two sets of gene symbols, with
no indication of physiological weight or direction. However,
any of the individual gene effects noted accordingly referenced
on the following website (http://www.polygenicpathways.co.uk/
pgingivalis.htm). The pathway analyses similarly depend upon
those made available by particular websites and pathways that
are more relevant may exist but remain inaccessible to the wider
public.
CONCLUSIONS
The host genes employed by P. gingivalis during its life cycle,
and those reacting to infection by the pathogen-host interaction
are enriched in GWASdb genes for several diseases where the
pathogen is suspected to play a contributory role. These notably
include AD, T2DM, and atherosclerosis. This was confirmed
for associated genes in the more stringent NHGRI-EBI GWAS
database. The genes misregulated in periodontal tissue or by
P. gingivalis or its components in macrophages also relate to
those misregulated in AD and atherosclerosis. It may be plausible
to suggest that the major effects of P. gingivalis relate to its
ability to disrupt barrier function and this could play a key
role in its downstream pathological events. Disrupted BBB
function caused by P. gingivalismay also be relevant to the many
other pathogens that have been associated with AD and related
diseases.
From a genetic standpoint, it is increasingly clear that
disease susceptibility genes relate not only to human physiology,
but also to that of the pathogens implicated in the same
disease. This suggests that pathogens and genes condition
each other’s effects. It is not yet clear how or whether
polymorphisms in these susceptibility genes influence the
disease promoting effects of this pathogen, and, in general,
there has been little work in this area. It is also likely
that such gene/pathogen interactions could determine the
extent to which P. gingivalis can influence the acute or
chronic aspects of periodontitis or other components of the
oral microbiome. From a medical standpoint it is however
evident that the prevention of periodontal disease or strategies
directed at keystone pathogens such as P. gingivalis could
have a major effect on the incidence and progression of AD,
cardiovascular diseases and type 2 diabetes, and possibly many
other disorders.
FUTURE PERSPECTIVES
This bioinformatics analysis supports the many documented
relationships between P. gingivalis infection and AD or its
comorbid conditions, T2DM and atherosclerosis. The key
effects of the pathogen may relate to barrier disruption and
inflammatory processes. Further studies should include animal
models to determine whether this pathogen can damage and
breach the BBB and whether it can access the brain and promote
the hallmark pathologies of AD, including Aβ deposition,
tau phosphorylation, inflammation and neuronal death in
relevant areas. It is also likely that targeting this and other
periodontal pathogens could be of benefit to a variety of human
diseases.
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